🎉 We are getting PacBio Revio!

We are thrilled to announce that IGF is taking a monumental leap in genomic research by adding PacBio’s cutting-edge Revio™ long-read sequencing system to our suite of tools. This revolutionary system, designed to provide an astounding 15 times more HiFi data, is set to redefine our capabilities in sequencing and genome analysis.

Why We’re Excited Coming Sooon

The Revio system is more than just an upgrade — it’s a game-changer. With the ability to sequence up to 1,300 human genomes per year at 30-fold coverage for under $1,000 per genome, we can now tackle projects on a scale previously unimaginable. From human genetics to cancer research, agricultural genomics, and beyond, the possibilities are endless.

PacBio’s Revio combines advanced SMRT Cell design and NVIDIA’s AI-enabled GPUs, offering:

• Unprecedented throughput with up to 100 million ZMWs for simultaneous molecule sequencing.
• Enhanced accuracy with HiFi sequencing technology.
• Direct detection of DNA methylation, thanks to deep learning integration.
• Improved efficiency, requiring 50% fewer consumables than its predecessor.

What This Means for Our Work

For us, the addition of Revio marks a new era of efficiency and innovation. The ability to conduct large-scale sequencing projects with shorter run times and reduced costs will enable us to:

• Accelerate breakthroughs in rare disease research.
• Explore complex plant and animal genomes with unmatched precision.
• Drive forward innovative solutions in agricultural biotechnology.
• The Revio system’s seamless workflow and flexibility mean we can operate continuously, maximizing productivity and ensuring faster turnaround for our projects.

Join Us on This Journey

We can’t wait to share the incredible discoveries that this new technology will make possible. Stay tuned as we begin integrating the Revio system into our operations and continue to push the boundaries of what’s possible in genomics.

Let’s revolutionize science together!